Tag Archives: Cardiovascular

Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease  Eli Lilly and Company Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity  CNBC Eli Lilly’s diabetes drug Mounjaro matches heart benefit of older treatment  statnews.com Eli Lilly Weight-Loss Drug Mounjaro …

TOPLINE: Moderate- to vigorous-intensity physical activity (MVPA) begins declining approximately 12 years before the onset of cardiovascular disease (CVD), with steeper drops 2 years before its onset. Black women consistently showed the lowest levels of MVPA and were at more than four times higher risk for low MVPA after a cardiovascular event than other groups. METHODOLOGY: Researchers analyzed data from …